Experts InSight

American Academy of Ophthalmology
  • 0,0 (0)
  • Medicina
  • Svaka dva tjedna

Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.

  1. prije 2 h

    The American Board of Ophthalmology: New Leadership and a Look Ahead

    Host Dr. Jay Sridhar welcomes Dr. Steven Gedde, the incoming CEO of the American Board of Ophthalmology (ABO), to discuss his outlook on medical education and the evolving board certification process. As medical knowledge now doubles approximately every 60 days, Dr. Gedde envisions the ABO shifting its focus from testing facts to assessing skills like communication, professionalism, and the use of technology. Although current surgical assessments focus on knowledge and decision-making, future evaluations may leverage AI and virtual reality to test technical competence.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

    41 min

  2. 25. lip

    Examining Reapplication to the Ophthalmology Residency Match

    Host Dr. Jay Sridhar welcomes ophthalmology program directors Drs. Chris Alabiad and Alice Zhang to discuss the ophthalmology residency match, the rising pool of reapplicants to the field, and how to mentor and advise students pursuing reapplication. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

    37 min

  3. 11. lip

    Central Retinal Artery Occlusions Revisited: Thoughts on TenCRAOS

    Do the benefits really outweigh the risks when it comes to the use of thrombolytic drugs for central retinal artery occlusion (CRAO)? Drs. Amanda Henderson and Michael Carper weigh in on the recently published Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS) and how ophthalmologists should proceed in their management of CRAO with tenecteplase (TNK) or another tissue plasminogen activator (tPA). For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

    15 min

  4. 28. svi

    Challenges in DME: the Evolution of Fluid Management

    With an abundance of therapeutic options for managing diabetic macular edema (DME), what patient characteristics inform your treatment decisions? Does the number of loading doses influence long-term macular fluid outcomes? How are you managing insurance-mandated step-therapy in your patients? In today's episode, host Dr. Jay Sridhar invites Drs. Durga Borkar and Carl Danzig to share how they've integrated new anti-VEGF therapies into clinical practice. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

    31 min

  5. 14. svi

    Of MIPS and Medicine: The Game of Cost Control and Reimbursements

    Is the Merit-based Incentive Payment System (MIPS) fulfilling its intended purpose, or is it just causing headaches? Dr. George Williams and Joe Reyes join host Dr. Andrew Pouw to share their expertise and experience with MIPS, including its evolution from prior medical cost control policies and how ophthalmologists can use the IRIS Registry to meet reporting requirements.  For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts

    43 min

  6. 30. tra

    Improving the Scientific Peer Review Process

    Drs. Durga Borkar and Katherine Talcott join host Dr. Jay Sridhar to brainstorm ideas for how to maintain and improve the current scientific peer review process in ophthalmology. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts

    33 min

  7. 16. tra

    Interferon Alpha for Cystoid Macular Edema

    Drs. Eric Suhler and Nick Butler join host Dr. Ben Young to discuss an old treatment for cystoid macular edema (CME) that may be new to many of us: interferon alpha. They review its use, side effects, and success thus far. Relevant papers discussed in this episode: Treatment of refractory cystoid macular edema with pegylated interferon alfa-2A: a retrospective chart review Interferon alpha 2b in the treatment of uveitic cystoid macular edema For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts

    25 min

  8. 2. tra

    Epiphora from Infancy to Adulthood

    Dr. Scott Goldstein joins host Dr. Amanda Redfern to share his approach to managing nasolacrimal duct obstruction (NLDO) in kids and his 3-step test for evaluating epiphora in adults, including how to identify complicating factors that may warrant surgical or procedural intervention. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

    38 min
Pogledajte sve (125)

Opis

Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology.

Informacije

  • Autor
    American Academy of Ophthalmology
  • Aktivne godine
    2021. - 2026.
  • Epizode
    125
  • Ocjena
    Korektno
  • Copyright
    © Copyright 2023 American Academy of Ophthalmology
  • Web‑stranica emisije
    Experts InSight

Također bi vam se moglo svidjeti